2 ms·
Yep that's part of the advance here. Identifying what those subsets are. This drug went on to be approved for mismatch repair deficient endometrial cancers in 2
by vikramkr 3y ago
Yep that's part of the advance here. Identifying what those subsets are. This drug went on to be approved for mismatch repair deficient endometrial cancers in 2023